<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A variety of transient focal neurological signs presenting at high altitude have been described without associated <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0002351" disease_type="Disease or Syndrome" abbrv="">mountain sickness</z:e> or other concurrent illness </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case series of <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo> at high altitude </plain></SENT>
<SENT sid="2" pm="."><plain>The term high-altitude <z:e sem="disease" ids="C0262497" disease_type="Mental or Behavioral Dysfunction" abbrv="">global amnesia</z:e> (HAGA) is introduced to indicate this condition, and the pathophysiology is discussed </plain></SENT>
<SENT sid="3" pm="."><plain>We hypothesize that because of the highly variable ventilatory response to <z:mp ids='MP_0005039'>hypoxia</z:mp> and to individual cerebral vasomotor reactivity, individuals with a marked hyperventilatory response could experience significant hypocapnic cerebral vasoconstriction that in turn could cause local <z:mp ids='MP_0005039'>hypoxia</z:mp> or <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> to particular regions of the brain and resulting transient focal neurological impairment </plain></SENT>
</text></document>